dc.contributor.author | Cetinkol, Yeliz | |
dc.contributor.author | Kokturk, Sibel | |
dc.contributor.author | Cirrik, Selma | |
dc.contributor.author | Ayyildiz, Sema Nur | |
dc.contributor.author | Noyan, Tevfik | |
dc.contributor.author | Benli, Erdal | |
dc.contributor.author | Ayyildiz, Ali | |
dc.date.accessioned | 2021-03-04T07:55:09Z | |
dc.date.available | 2021-03-04T07:55:09Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Kokturk S., Benli E., Ayyildiz A., Cirrik S., Cetinkol Y., Ayyildiz S. N. , Noyan T., "Positive outcomes of phosphodiesterase type 5 inhibitor on histopathologic and biochemical changes induced by ureteral obstruction", REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.65, sa.3, ss.388-393, 2019 | |
dc.identifier.issn | 1806-9282 | |
dc.identifier.other | av_6099ef8c-69db-40cb-aebd-69893fae49e4 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/67396 | |
dc.identifier.uri | https://doi.org/10.1590/1806-9282.65.3.388 | |
dc.description.abstract | OBJECTIVES: We examined the effects of tadalafil, one of the phosphodiesterase type 5 (PDE5) inhibitors, in a rat model of with partial and complete unilateral ureteral obstruction (UUO). | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | Positive outcomes of phosphodiesterase type 5 inhibitor on histopathologic and biochemical changes induced by ureteral obstruction | |
dc.type | Makale | |
dc.relation.journal | REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | |
dc.contributor.department | Ordu Üniversitesi , , | |
dc.identifier.volume | 65 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 388 | |
dc.identifier.endpage | 393 | |
dc.contributor.firstauthorID | 104868 | |